| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Todd C. Brady, M.D., Ph.D.
Also a director
President and CEO
Title from the Form 4 dated Jun 3, 2026
|
54 | Not stated | $4,704,179 | |
|
Michael Alfieri
Principal Financial Officer and Principal Accounting Officer
|
61 |
Since 2024
2 years
|
Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Jun 10, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Todd C. Brady, M.D., Ph.D.
CEO
|
54 |
2005
21 years
|
Not independent |
Stock Option Committee
|
None stated | Paid as CEO | |
|
Nancy B. Miller-Rich
|
67 |
2020
6 years
|
Independent |
Compensation Committee
|
4D Molecular Therapeutics, Inc. | $177,472 | |
|
Ben R. Bronstein, M.D.
|
76 |
2010
16 years
|
Independent |
Nominating/Corporate Governance Committee · Chair
|
None stated | $192,719 | |
|
Richard H. Douglas, Ph.D.
|
73 |
2016
10 years
|
Not stated | None stated | Novavax, Inc., MaxCyte, Inc. | $225,216 | |
|
Gary M. Phillips, M.D.
|
60 |
2009
17 years
|
Independent |
Compensation Committee · Chair
|
None stated | $196,218 | |
|
Neal S. Walker, D.O.
|
57 |
2013
13 years
|
Independent |
Compensation Committee
|
Aclaris Therapeutics, Inc. | $177,472 | |
|
Martin J. Joyce, M.B.A.
|
72 |
2013
13 years
|
Not stated |
Audit Committee · Chair
|
None stated | $197,719 | |
|
Darlene Deptula-Hicks
Joined Jun 9, 2026
|
- | - | Independent |
Audit Committee · Chair
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...